2-溴-5-氯-4-甲基苯胺合成路线 (共 11 条)
反应条件
hydrogenchloride; acetic acid T=118°C; 24 h;
参考文献
Cancer Research Technology Limited
Patent: US6699861 B1, 2004 ;
Location in patent: Page column 14-15 ;
US 6699861 B1
反应条件
N-bromosuccinmide in dichloromethane T=20°C; 0.166667 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GMBH
Patent: WO2005/103054 A2, 2005 ;
Location in patent: Page/Page column 71 ;
WO 2005/103054 A2
反应条件
bromine; acetic acid in ethyl acetate T=5°C; 0.166667 h;
参考文献
Journal of Medicinal Chemistry, , vol. 45, # 17 p. 3692 - 3702
反应条件
1: 48 percent / glacial AcOH; Br2 / 1.5 h / 15 °C 2: 94 percent / AcOH; conc. HCl / 24 h / 118 °C View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 45, # 17 p. 3692 - 3702
反应条件
1: 6.52 g / N-methylpyrrolidinone / 2 h / 163 °C 2: 93 percent / aq. KOH; H2O2 / 2 h / 130 °C 3: 97 percent / tetrahydrofuran / 6 h / 20 °C 4: 90 percent / DMAP / 3 h / 80 °C 5: 90 percent / pyridine / dimethylformamide / 2 h / 20 °C 6: 0.230 g / methanol; tetrahydrofuran / 26 h / 20 °C 7: 76 percent / 48percent aq. HBr / 7 h / 120 °C 8: 98 percent / DMAP; Et3N / CH2Cl2 / 0.5 h / 20 °C 9: 51 percent / NBS; dibenzoyl peroxide / CCl4 / 3.83 h / 85 °C / Irradiation 10: 73 percent / 2,6-lutidine / dimethylformamide / 5.5 h / 120 °C 11: 80 percent / aq. NaOH / tetrahydrofuran / 1 h / 20 °C 12: 94 percent / Et3N / CH2Cl2 / 0.92 h 13: 77 percent / CH2Cl2 / 2.5 h / 20 °C 14: 0.142 g / TFA / CH2Cl2 / 0.92 h / 20 °C 15: PyBOP; diisopropylethylamine / dimethylformamide / 3 h View Scheme
参考文献
Bavetsias; Skelton; Yafai; Mitchell; Wilson; Allan; Jackman
Journal of Medicinal Chemistry, 2002 , vol. 45, # 17 p. 3692 - 3702
反应条件
1: 6.52 g / N-methylpyrrolidinone / 2 h / 163 °C 2: 93 percent / aq. KOH; H2O2 / 2 h / 130 °C 3: 97 percent / tetrahydrofuran / 6 h / 20 °C 4: 90 percent / DMAP / 3 h / 80 °C 5: 90 percent / pyridine / dimethylformamide / 2 h / 20 °C 6: 0.230 g / methanol; tetrahydrofuran / 26 h / 20 °C 7: 76 percent / 48percent aq. HBr / 7 h / 120 °C 8: 98 percent / DMAP; Et3N / CH2Cl2 / 0.5 h / 20 °C 9: 51 percent / NBS; dibenzoyl peroxide / CCl4 / 3.83 h / 85 °C / Irradiation 10: 73 percent / 2,6-lutidine / dimethylformamide / 5.5 h / 120 °C View Scheme
参考文献
Bavetsias; Skelton; Yafai; Mitchell; Wilson; Allan; Jackman
Journal of Medicinal Chemistry, 2002 , vol. 45, # 17 p. 3692 - 3702
反应条件
1: 6.52 g / N-methylpyrrolidinone / 2 h / 163 °C 2: 93 percent / aq. KOH; H2O2 / 2 h / 130 °C 3: 97 percent / tetrahydrofuran / 6 h / 20 °C 4: 90 percent / DMAP / 3 h / 80 °C 5: 90 percent / pyridine / dimethylformamide / 2 h / 20 °C 6: 0.230 g / methanol; tetrahydrofuran / 26 h / 20 °C 7: 76 percent / 48percent aq. HBr / 7 h / 120 °C 8: 98 percent / DMAP; Et3N / CH2Cl2 / 0.5 h / 20 °C View Scheme
参考文献
Bavetsias; Skelton; Yafai; Mitchell; Wilson; Allan; Jackman
Journal of Medicinal Chemistry, 2002 , vol. 45, # 17 p. 3692 - 3702
反应条件
in 1-methyl-pyrrolidin-2-one T=163°C; 2 h;
参考文献
Cancer Research Technology Limited
Patent: US6699861 B1, 2004 ;
Location in patent: Page column 15 ;
US 6699861 B1
反应条件
1-methyl-pyrrolidin-2-one T=163°C; 2 h;
参考文献
Bavetsias; Skelton; Yafai; Mitchell; Wilson; Allan; Jackman
Journal of Medicinal Chemistry, 2002 , vol. 45, # 17 p. 3692 - 3702
反应条件
1: 6.52 g / N-methylpyrrolidinone / 2 h / 163 °C 2: 93 percent / aq. KOH; H2O2 / 2 h / 130 °C View Scheme
参考文献
Bavetsias; Skelton; Yafai; Mitchell; Wilson; Allan; Jackman
Journal of Medicinal Chemistry, 2002 , vol. 45, # 17 p. 3692 - 3702